Harte Hanks Inc

Name: Harte Hanks Inc standardized financial statements, quarterly
Creator: Listed

HHSNasdaqCIK 45919IndustrialsFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$38.0m, Q2 FY2026

Operating income−$4.5m, Q2 FY2026

Net income−$5.0m, Q2 FY2026

Harte Hanks Inc, income statement, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Revenue	$m	47.1	49.5	45.4	45.0	47.6	47.1	41.6	38.6	39.5	39.9	37.3	38.0
Selling, general and administrative	$m	4.9	4.6	5.9	5.9	5.3	5.7	5.8	5.5	5.1	5.7	5.6	8.8
Operating income	$m	2.9	(2.3)	0.4	1.4	1.9	(1.6)	(0.0)	0.0	0.5	(0.1)	(0.8)	(4.5)
Interest expense	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Income tax	$m	1.9	(2.0)	(0.1)	(9.0)	0.9	0.6	(0.2)	(0.1)	2.6	(2.5)	(0.4)	0.1
Net income	$m	0.6	(2.0)	(0.2)	(27.8)	0.1	(2.4)	(0.4)	(0.3)	(2.3)	2.2	(0.6)	(5.0)
Diluted EPS	$ per share	0.08	not reported	(0.02)	(3.84)	0.02	not reported	(0.05)	(0.05)	(0.31)	not reported	(0.08)	(0.67)
Basic EPS	$ per share	0.09	not reported	(0.02)	(3.84)	0.02	not reported	(0.05)	(0.05)	(0.31)	not reported	(0.08)	(0.67)

Balance sheet

Cash and equivalents$5.2m, Q2 FY2026

Shareholders' equity$15.3m, Q2 FY2026

Harte Hanks Inc, balance sheet, quarterly
Line item	Unit	Q3 FY20232023-09-30	FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Cash and equivalents	$m	13.3	18.4	11.5	11.0	5.9	9.8	8.7	4.7	6.5	5.6	4.5	5.2
Current assets	$m	62.2	65.2	57.8	55.0	53.8	53.6	53.7	50.0	48.7	46.3	45.8	45.4
Total assets	$m	111	123	113	110	108	102	101	95.0	92.7	91.8	90.4	88.1
Current liabilities	$m	38.7	48.1	40.2	36.4	36.9	35.1	36.1	31.2	33.0	30.2	30.7	34.9
Total liabilities	$m	90.3	103	93.5	89.1	87.1	80.1	79.2	72.8	72.8	71.3	70.3	72.7
Long-term debt	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Current portion of debt	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Short-term borrowings	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	0.0	not reported	3.0
Shareholders' equity	$m	20.5	19.9	20.0	20.6	21.0	21.7	21.4	22.2	19.9	20.5	20.1	15.4

Cash flow

Operating cash flow−$2.1m, Q2 FY2026

Capital expenditure−$41.0k, Q2 FY2026

Share repurchases$0, Q4 FY2024

Harte Hanks Inc, cash flow, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$k	1,523	4,367	(5,692)	1,608	(2,948)	4,045	(818)	(4,850)	3,196	737	(575)	(2,072)
Capital expenditure	$k	224	1,332	526	682	1,911	627	105	223	1,006	1,423	347	(41.0)
Dividends paid	$k	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Share repurchases	$k	491	0.0	not reported	not reported	0.0	0.0	not reported	not reported	not reported	not reported	not reported	not reported

Diluted shares (weighted)7.43m, Q2 FY2026

Harte Hanks Inc, shares, quarterly
Line item	Unit	Q3 FY20222022-09-30	Q1 FY20232023-03-31	Q2 FY20232023-06-30	Q3 FY20232023-09-30	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Diluted shares (weighted)	k shares	7,524	7,425	7,505	7,314	7,236	7,257	7,398	7,360	7,382	7,415	7,416	7,431

Shares outstanding: 7.45m at Jul 31, 2026, from the cover of the 10-Q filed Aug 14, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:18 ET. Listed shows no prices and gives no investment advice.